We are live on
!
Find out more
AC
AXQ Capital Portfolio holdings
AUM
$777M
1-Year Est. Return
9.87%
This Fund
S&P 500
This Quarter
Est. Return
-2.08%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$777M
AUM Growth
+$334M
(+75%)
Cap. Flow
+$396M
Cap. Flow
% of AUM
50.94%
Top 10 Holdings %
Top 10 Hldgs %
6.27%
Holding
1,320
New
618
Increased
231
Reduced
124
Closed
347
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$7M |
| 2 |
Cleveland-Cliffs
CLF
|
+$6.43M |
| 3 |
TPG
TPG
|
+$5.71M |
| 4 |
Ford
F
|
+$5.07M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$4.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$2.55M |
| 2 |
Honeywell
HON
|
+$2.51M |
| 3 |
Lennar Class A
LEN
|
+$2.39M |
| 4 |
Broadcom
AVGO
|
+$2.24M |
| 5 |
EOG Resources
EOG
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.64% |
| 2 | Technology | 17.26% |
| 3 | Industrials | 13.44% |
| 4 | Healthcare | 12.8% |
| 5 | Consumer Discretionary | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPTU
951
Optimum Communications Inc
OPTU
$367M
| $32.1K | ﹤0.01% |
+24,665
| New | +$38.8K |
|
952
Lexicon Pharmaceuticals
LXRX
$999M
| $31.4K | ﹤0.01% |
+20,150
| New | +$29.3K |
|
|
DGXX
953
Digi Power X Inc
DGXX
$395M
| $28.7K | ﹤0.01% |
+14,137
| New | +$37K |
|
954
Caribou Biosciences
CRBU
$165M
| $28.5K | ﹤0.01% |
+15,000
| New | +$25.7K |
|
|
GLDG
955
GoldMining Inc
GLDG
$189M
| $27.7K | ﹤0.01% |
+23,294
| New | +$34.9K |
|
956
Treace Medical Concepts
TMCI
$268M
| $26.1K | ﹤0.01% |
19,507
+2,562
| +15% | +$5.11K |
|
957
Invivyd
IVVD
$195M
| $26K | ﹤0.01% |
+19,984
| New | +$36.7K |
|
|
SNBR
958
DELISTED
Sleep Number
SNBR
| $26K | ﹤0.01% |
+14,465
| New | +$109K |
|
959
3D Systems Corp
DDD
$456M
| $25.7K | ﹤0.01% |
+13,646
| New | +$30.3K |
|
|
THM
960
International Tower Hill Mines
THM
$573M
| $24.8K | ﹤0.01% |
+10,779
| New | +$27.5K |
|
961
Equillium
EQ
$162M
| $23.9K | ﹤0.01% |
+11,935
| New | +$19.6K |
|
|
EU
962
enCore Energy
EU
$241M
| $22.8K | ﹤0.01% |
+12,683
| New | +$32.4K |
|
963
New Horizon Aircraft
HOVR
$130M
| $21.9K | ﹤0.01% |
+15,509
| New | +$29.5K |
|
964
JELD-WEN Holding
JELD
$105M
| $21.3K | ﹤0.01% |
+17,182
| New | +$37.6K |
|
965
Immunic
IMUX
$201M
| $20.1K | ﹤0.01% |
+1,815
| New | +$16.3K |
|
966
Cerus
CERS
$621M
| $18.5K | ﹤0.01% |
10,147
-20,266
| -67% | -$44.2K |
|
967
Neuronetics
STIM
$132M
| $17.8K | ﹤0.01% |
+12,308
| New | +$19.5K |
|
968
Rackspace Technology
RXT
$1.07B
| $15.6K | ﹤0.01% |
+15,939
| New | +$19.4K |
|
969
Microvast
MVST
$317M
| $15.6K | ﹤0.01% |
+10,400
| New | +$25K |
|
970
Pacific Biosciences
PACB
$438M
| $14.5K | ﹤0.01% |
+10,974
| New | +$19.6K |
|
971
Fate Therapeutics
FATE
$318M
| $12.8K | ﹤0.01% |
+10,706
| New | +$13K |
|
972
ECARX Holdings
ECX
$405M
| $9.99K | ﹤0.01% |
+10,219
| New | +$16.2K |
|
973
Gossamer Bio
GOSS
$72.6M
| $6.71K | ﹤0.01% |
20,421
-42,696
| -68% | -$67.1K |
|
974
Aaon
AAON
$8.7B
| – | – |
-3,052
| Closed | -$233K |
|
975
AbbVie
ABBV
$454B
| – | – |
-2,469
| Closed | -$564K |
|
Similar funds
NA
BWA
PC
TCM
BPIM
WF
PA
LA
AXQ Capital's Q1 2026 Portfolio in Review
As of Q1 2026, AXQ Capital held 1,320 positions worth $777M, up 75% from $443M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
AXQ Capital deployed $396M of net new capital in Q1 2026, opening 618 new positions and adding to 231 existing holdings. Its largest new stake was TPG: 111,339 shares worth $4.51M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Stryker, an estimated $2.04M trimmed.
- AXQ Capital's largest Q1 2026 buy was TPG: 111,339 shares worth $4.51M.
- AXQ Capital added most to Boston Scientific in Q1 2026, an estimated $7M increase.
- AXQ Capital's biggest Q1 2026 reduction was Stryker, cutting an estimated $2.04M.
- AXQ Capital fully exited Marsh in Q1 2026, selling an estimated $2.55M.
- AXQ Capital's ten largest holdings make up 6.3% of its $777M portfolio in Q1 2026.
- AXQ Capital opened 618 new positions and closed 347 in Q1 2026.
- AXQ Capital's portfolio value rose 75% quarter-over-quarter to $777M.
Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.